UBS maintains Cano Health at 'neutral' with a price target of $1.00

An analyst from UBS maintained Cano Health (NYSE: CANO) at 'neutral' and a price target of $1.00 from a prior price target of $1.25.
Prior to this rating, Cano Health had 3 buy ratings, 6 hold ratings, and 2 sell ratings.
For consensus analyst estimates and price targets on Cano Health, click here. For more news on Cano Health, click here.
Cano Health's stock price closed at $1.03. They are down -31.33% in the last month and down -75.36% in the last 12 months.
According to Investing Pro, Cano Health's fair value is $1.27, an upside of 12.99%. Cano Health's fair value comes with a medium degree of uncertainty, according to InvestingPro.
Check out Cano Health's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or